DNTH
DIANTHUS THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
DIANTHUS THERAPEUTICS INC (DNTH) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$190.69M; the largest are Ken Griffin, Baker Bros. Advisors, Izzy Englander. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 2 trimmed, 1 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Cooling
Common-stock holders41 also report options
Congress trades0
Price$87.16vs quarter-end-10.59%
Sectors0
This quarter's moves
Top holderNew1
Added0
Trimmed / sold3
Ken GriffinCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
Value $83.07M0.4% of portfolio852,1642026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Baker Bros. Advisors | $83.07M | 0.4% | Hold |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $4.23M— of portfolio43,4002026 Q2
Value $740.8K— of portfolio7,6002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinPUT | $4.23M | — | — |
| Ken GriffinCALL | $740.8K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.